Ocular Responses to Short and Long-term Lens Wear

NCT ID: NCT00722891

Last Updated: 2019-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to determine whether ocular surface sensitivity to pneumatic, mechanical and chemical stimulation would be affected by the use of the combination of a specific silicone hydrogel lens material with two lens care products over a four week period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ametropia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Purevision Lens with ReNu

Purevision Lenses with ReNu Multiplus Solution

Group Type ACTIVE_COMPARATOR

Purevision Lenses with ReNu Multiplus

Intervention Type DEVICE

Purevision lenses using ReNu Multiplus lens solution for 28 days

Purevision Lenses with RepleniSH

Purevision Lenses with Optifree RepleniSH Solution

Group Type ACTIVE_COMPARATOR

Purevision Lenses with Optifree RepleniSH

Intervention Type DEVICE

Purevision lenses using Optifree RepleniSH lens solution for 28 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Purevision Lenses with ReNu Multiplus

Purevision lenses using ReNu Multiplus lens solution for 28 days

Intervention Type DEVICE

Purevision Lenses with Optifree RepleniSH

Purevision lenses using Optifree RepleniSH lens solution for 28 days

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Balafilcon A Balafilcon A

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Is at least 17 years old and has full legal capacity to volunteer;
* Is correctable to a visual acuity of 6/7.5 (20/25) or better (both eyes) with their habitual vision correction;
* Is a current soft lens wearer and wears contact lenses six or more days/week;
* Has clear corneas and no active ocular disease.

Exclusion Criteria

* Has any clinically significant blepharitis or dry eye;
* Has undergone corneal refractive surgery;
* Is aphakic;
* Has any active ocular disease;
* Has any systemic disease affecting ocular health;
* Is using any systemic or topical medications that may affect ocular health;
Minimum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bausch & Lomb Incorporated

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Trefford Simpson, DipOptom,MSc,PhD

Role: PRINCIPAL_INVESTIGATOR

University of Waterloo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Waterloo

Waterloo, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P/289/07/B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.